A TCF1:Glucocorticoid regulatory circuit controls IL-23-driven Th17 pathogenicity
TCF1:糖皮质激素调节电路控制 IL-23 驱动的 Th17 致病性
基本信息
- 批准号:10635984
- 负责人:
- 金额:$ 51.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:AnabolismAutomobile DrivingBiologyBypassCNS autoimmunityCellsCentral Nervous SystemCentral Nervous System DiseasesDataDefectDevelopmentDiseaseDisease susceptibilityEnzymesEpigenetic ProcessGene DeletionGenesGenetic TranscriptionGenetic VariationGlucocorticoid ReceptorGlucocorticoidsGranulocyte-Macrophage Colony-Stimulating FactorHelper-Inducer T-LymphocyteHomeostasisHumanIL17 geneImpairmentInflammationInflammatoryInvestigationKnockout MiceKnowledgeLinkMature T-LymphocyteMediatingMediatorModelingMultiple SclerosisMusPathogenicityPatientsPredispositionPrevalenceRegulationRelapsing-Remitting Multiple SclerosisRoleSignal TransductionSteroid biosynthesisT-Cell DevelopmentT-LymphocyteTCF Transcription FactorTestingThymocyte SelectionTissuesautoimmune inflammationbeta cateninclinically relevantconditional knockoutepigenomegenetic variantgenome wide association studyin vivoinsightinterleukin-23novelnovel therapeutic interventionprogramsrestrainttooltranscriptome
项目摘要
PROJECT SUMMARY
CD4+ IL-17-producing T helper cells (Th17) are known drivers of central nervous system (CNS) autoimmune
inflammation in multiple sclerosis (MS), yet not all Th17 cells drive disease. Indeed, two major Th17 subtypes
have been described in both mice and humans: homeostatic or non-pathogenic (npTh17) that maintain the
steady state in tissue and inflammatory or pathogenic Th17 (pTh17) that drive destructive tissue inflammation.
Importantly, npTh17 are precursors of pTh17 and IL-23 is known to be the switch factor for conversion of npTh17
to pTh17. However, the mechanisms by which IL-23 drives this conversion are not well understood. Identifying
these mechanisms will provide critical insight for the development of novel therapeutic interventions for MS.
Genetic variants in TCF7, the gene encoding the transcription factor TCF-1, have been associated with disease
susceptibility in MS in genome-wide association studies, but the underlying mechanisms remain unknown.
Notably, TCF-1 has been implicated in Th17 biology, but its role remains unclear due to conflicting data
generated in models that have either defective T cell development or that study TCF-1 indirectly. Using mice that
conditionally delete Tcf7 only in mature T cells, and thus have normal T cell development, we have found that
TCF-1-deficient Th17 cells may not require IL-23R signaling for acquiring pathogenic potential. Indeed, we have
found that TCF-1 is differentially regulated in npTh17 and pTh17 in vivo and that IL-23 shuts down TCF-1
expression. Our preliminary data further uncover a putative regulatory circuit that links IL-23, TCF-1, and
endogenous glucocorticoid (GC) signaling. We have found that npTh17 are steroidogenic. They can produce
GCs, which in turn, sustain TCF-1 expression, oppose IL23R signaling, and restrain Th17 pathogenicity. In
contrast, IL-23 shuts down steroidogenesis in npTh17 cells. Accordingly, we hypothesize that a TCF-1-
glucocorticoid regulatory circuit determines IL-23-driven pathogenicity in Th17 cells. We have generated
several novel conditional knock-out mice with which we can study the role of TCF-1, the glucocorticoid receptor
(GR), and cell-intrinsic steroidogenesis specifically in mature T cells. We will use these tools to mechanistically
dissect this novel regulatory circuit. We propose the following aims: 1) Define the role of TCF-1 in opposing IL-
23-driven Th17 pathogenicity; 2) Determine how glucocorticoid signaling regulates TCF-1 expression, IL23R
signaling, and Th17 pathogenicity; and 3) Determine the role of cell-intrinsic steroidogenesis in opposing Th17
pathogenicity.
Our proposed investigation is highly clinically relevant given the association of genetic variants of TCF7 with
susceptibility to MS and the use of GCs to treat relapses in patients with relapsing-remitting MS (RR-MS).
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANA C ANDERSON其他文献
ANA C ANDERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANA C ANDERSON', 18)}}的其他基金
Role of metabolic crosstalk in determining immunity during tumor progression
代谢串扰在肿瘤进展过程中决定免疫的作用
- 批准号:
10718070 - 财政年份:2023
- 资助金额:
$ 51.8万 - 项目类别:
Role of Tim-3 in determining T cell immunity
Tim-3 在决定 T 细胞免疫中的作用
- 批准号:
9024492 - 财政年份:2015
- 资助金额:
$ 51.8万 - 项目类别:
Regulation of stem-like CD8+ T cells and their role in immunotherapy
干细胞样 CD8 T 细胞的调节及其在免疫治疗中的作用
- 批准号:
10400137 - 财政年份:2015
- 资助金额:
$ 51.8万 - 项目类别:
Role of Tim-3 in determining T cell immunity
Tim-3 在决定 T 细胞免疫中的作用
- 批准号:
9210064 - 财政年份:2015
- 资助金额:
$ 51.8万 - 项目类别:
Regulation of stem-like CD8+ T cells and their role in immunotherapy
干细胞样 CD8 T 细胞的调节及其在免疫治疗中的作用
- 批准号:
10211084 - 财政年份:2015
- 资助金额:
$ 51.8万 - 项目类别:
Regulation of stem-like CD8+ T cells and their role in immunotherapy
干细胞样 CD8 T 细胞的调节及其在免疫治疗中的作用
- 批准号:
10622463 - 财政年份:2015
- 资助金额:
$ 51.8万 - 项目类别:
Genetic Elements that Influence Susceptibility to CNS Autoimmunity
影响中枢神经系统自身免疫易感性的遗传因素
- 批准号:
7371005 - 财政年份:2006
- 资助金额:
$ 51.8万 - 项目类别:
Genetic Elements that Influence Susceptibility to CNS Autoimmunity
影响中枢神经系统自身免疫易感性的遗传因素
- 批准号:
7176038 - 财政年份:2006
- 资助金额:
$ 51.8万 - 项目类别:
相似海外基金
Establishment of a method for evaluating automobile driving ability focusing on frontal lobe functions and its application to accident prediction
以额叶功能为中心的汽车驾驶能力评价方法的建立及其在事故预测中的应用
- 批准号:
20K07947 - 财政年份:2020
- 资助金额:
$ 51.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation of the Effectiveness of Multi-Professional Collaborative Assessment of Cognitive Function and Automobile Driving Skills and Comprehensive Support
认知功能与汽车驾驶技能多专业协同评估效果评价及综合支持
- 批准号:
17K19824 - 财政年份:2017
- 资助金额:
$ 51.8万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of Flexible Automobile Driving Interface for Disabled People
残疾人灵活汽车驾驶界面开发
- 批准号:
25330237 - 财政年份:2013
- 资助金额:
$ 51.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Automobile driving among older people with dementia: the effect of an intervention using a support manual for family caregivers
患有痴呆症的老年人的汽车驾驶:使用家庭护理人员支持手册进行干预的效果
- 批准号:
23591741 - 财政年份:2011
- 资助金额:
$ 51.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)